Parenteral Nanoemulsion for Optimized Delivery of GL-II-73 to the Brain-Comparative In Vitro Blood-Brain Barrier and In Vivo Neuropharmacokinetic Evaluation.
Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Kristina JezdićDepartment of Pharmacology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0009-0000-2208-2252
Jelena ĐokovićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0000-0003-0936-4276
Ivan JančićDepartment of Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.
Tanja IlićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0000-0002-1937-1704
Biljana BufanDepartment of Microbiology and Immunology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0000-0003-1861-5700
Bojan MarkovićDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0000-0002-3825-4394
Jana IvanovićDepartment of Pharmacology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.
Tijana StankovićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.
Nebojša D CekićFaculty of Technology, University of Niš, 16000 Leskovac, Serbia.
Vassiliki PapadimitriouInstitute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.ORCID 0000-0002-6632-3115
Dishary SharminDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.
Prithu MondalDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.
James M CookDepartment of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA.ORCID 0000-0001-5512-3022
Snežana D SavićDepartment of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0000-0002-6236-9730
Miroslav M SavićDepartment of Pharmacology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.ORCID 0000-0002-6934-9193
Funding
Tolerance and Physical Dependence after Chronic Benzodiazepine TreatmentR01DA043204 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI JAMES K ROWLETT · 2017 to 2026
$4.3M
Benzodiazepine Choice and Polydrug UseR01DA054177 · NIDA · UNIVERSITY OF MISSISSIPPI MED CTR · PI Sally L Huskinson · 2022 to 2026
$2.5M
GABA-A receptor subtype mechanisms and the abuse-related effects of alcoholR01AA029023 · NIAAA · UNIVERSITY OF MISSISSIPPI MED CTR · PI PLATT, DONNA M · 2020 to 2024
$2.4M
NIAAA NIH HHS R01 AA029023NIDA NIH HHS R01 DA043204NIDA NIH HHS R01 DA054177NIH HHS 2R01 DA043204-06A1NIH HHS R01 AA029023NIH HHS R01 DA054177Science Fund of the Republic of Serbia 7749108
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Parenteral Nanoemulsion for Optimized Delivery of GL-II-73 to the Brain-Comparative In Vitro Blood-Brain Barrier and In Vivo Neuropharmacokinetic Evaluation. · full record | Socratic